
INTRODUCTION
The pathogenesis of metabolic disorders in type 2 diabetes mellitus—disorders of carbohydrate, lipid, and mineral metabolism—places therapeutic nutrition and adherence to a diet alongside drug therapy. (Feldeisen SE, Tucker KL Nutritional strategies in the prevention and treatment of metabolic syndrome. Appl Physiol Nutr Metab. 2007 Feb;32(1):46-60). In some cases, careful adherence to a dietary regimen makes it possible to postpone oral glucose-lowering medication, achieve glycaemic and dyslipoproteinaemia correction, and reduce the dose of antihypertensive medicines.
According to balanced-diet standards in developed countries, fibre and pectin intake should be at least 20–25 g per day, especially for people prone to constipation and older adults. For diabetes and atherosclerosis, a fibre intake of 30–45 g per day is recommended. In people with diabetes, a diet containing 82 g of dietary fibre helps lower blood cholesterol and glucose and makes it possible to reduce the dose of oral glucose-lowering medicines. (П.Н. Бондар, А.А. Пешко, Г.П. Михальчишин, Л.О. Кононенко, Д.В. Кириенко, Н.И. Лопушенко ФАРМАКОТЕРАПИЯ ИНСУЛИННЕЗАВИСИМОГО САХАРНОГО ДИАБЕТА. Украинский медицинский журнал №3(23) май-июнь 2001г).
The use of dietary fibre and a diet enriched with phosphorus and calcium can reduce the incidence of dental caries in diabetes (Ciglar L, Skaljac G, Sutalo J, Keros J, Jankovic B, Knezevic A. Influence of diet on dental caries in diabetics. Coll Antropol. 2002 Jun;26(1):311-7).
The dietary complex “Vegetabs™ with lemon” was specifically developed for nutritional support of people with diabetes. It contains a complex of food components rich in dietary fibre based on various types of polysaccharides, flavonoids, beta-carotene, vitamins B1, C, B, B2, Be, E, K, PP, folic acid, as well as potassium and magnesium (Jerusalem artichoke, lemon, chitosan oligomers, and celery powders).
Jerusalem artichoke contains a large amount of inulin, which undergoes little degradation in the gastrointestinal tract. As a practically insoluble dietary fibre, it helps move intestinal contents more quickly into the distal small intestine, where glucose absorption is limited. In addition, insoluble dietary fibre reduces the rate of starch hydrolysis and thereby also limits the rate of glucose absorption. This can reduce postprandial glycaemia. (D. Jenkis et al., 1984).
Water-soluble dietary fibre reduces the availability of nutrients to digestive enzymes, thereby slowing glucose absorption and reducing postprandial hyperglycaemia. It also reduces fatty-acid absorption and increases cholesterol excretion. Dietary fibre does not increase insulin secretion, which is especially important in hyperinsulinaemia. Dietary fibre stimulates bile excretion; increased excretion stimulates bile-acid synthesis, thereby lowering cholesterol levels. Dietary fibre helps soften stools and is effective for constipation.
Pectin is one of the most important components of dietary fibre. It is an acidic polysaccharide found in many plants. (В.В. Корпачев. Сахара и сахарозаменители. Киев Книга 2004, с 320). Pectin was first isolated from Jerusalem artichoke (pectin substances account for about 11% of its dry mass), and it is particularly abundant in citrus fruits; therefore, “Vegetabs™ with lemon” fully supplies the body with this dietary-fibre component.
Along with Jerusalem artichoke, celery, and lemon powders, “Vegetabs™ with lemon” contains unique beneficial chitosan oligomer compounds said to be effective against diabetes (Hayashi K, Ito M. Antidiabetic action of low molecular weight chitosan in genetically obese diabetic KK-Ay mice./ Biol Pharm Bull. 2002 Feb;25(2):188-92.2 Tai TS, Sheu WH, Lee WJ, Yao HT, Chiang MT. Effect of chitosan on plasma lipoprotein concentrations in type 2 diabetic subjects with hypercholedterolemia./ Diabetes Care. 2000 Nov; 23(11):1703-4.). (Miura T, Usami M, Tsuura Y, Ishida H, Seino Y.Hypoglycemic and hypolipidemic effect of chitosan in normal and neonatal streptozocin-induced diabetic mice./Biol Pharm Bull. 1995 Nov;18(11):1623-5) (Kondo Y, Nakatani A, Hayashi K, Ito M. Low molecular weight chitosan prevents the progression of low dose streptozotocin-induced slowly progressive diabetes mellitus in mice./Biol PharmBull.200Dec;23(12):1458-64).
Because of its complex of biologically active substances, “VegetabsTM with lemon” is said to normalise carbohydrate and lipid metabolism, regulate intestinal function, and promote natural cleansing of the body by supporting the growth and maintaining optimal levels of bifidobacteria and lactobacilli while suppressing putrefactive microflora. The transport function of the product's chitosan oligomers is said to increase the bioavailability of beneficial substances (vitamins and micro- and macroelements) contained in the plant components—Jerusalem artichoke and celery.
The Jerusalem artichoke plant powder in “Vegetabs™ with lemon” contains pectin substances, inulin, fibre, macronutrients (magnesium, potassium, calcium), micronutrients (manganese, copper, zinc), vitamins (B1, B2, C), and essential amino acids (arginine, valine, histidine, isoleucine, leucine, lysine, methionine, threonine, tryptophan, phenylalanine).
The celery-root plant powder in “Vegetabs with lemon” contains mineral salts, glycosides, oxalic acid, and vitamins (C, B1, B2, PP, E, U [anti-ulcer]).
The plant components of “Vegetabs™ with lemon” (Jerusalem artichoke, celery, and chitosan oligomers) are presented as a balanced combination of bioavailable substances.
Study objective: to determine the effect of the dietary-fibre-based product “VegetabsTM with lemon” on carbohydrate metabolism in patients with non-insulin-dependent diabetes mellitus, and to assess its effectiveness and tolerability.
Study tasks:
- To identify the effect of a diet enriched with “VegetabsTM with lemon” on fasting blood glucose levels in patients with NIDDM.
- To determine the effect of a diet enriched with “VegetabsTM with lemon” on postprandial hyperglycaemia.
- To assess the effect of a diet enriched with “VegetabsTM with lemon” on lipid metabolism.
- To assess the effect of a diet enriched with “VegetabsTM with lemon” on gastrointestinal function.
- To compare the results with a control group.
Study design
The study was conducted at City Clinical Hospital No. 35 from 20 December 2006 to 15 April 2007. A randomised comparative study was conducted in 40 patients in parallel groups. Participants were assigned to groups by random sampling. Patients with glucose levels (>6{,}1) ( ext{mmol/L}) were included. They had been admitted to the internal medicine department either for diabetes treatment (to achieve control and select therapy) or for intercurrent diseases—exacerbation of coronary heart disease, hypertension, or irritable bowel syndrome.
Exclusion criteria
Exclusion criteria were uncontrolled arterial hypertension, morbid obesity, severe stroke, iron-deficiency anaemia, tuberculosis, cancer, cachexia, asthma, rheumatic diseases, leukaemia, trauma, and allergic reactions to citrus fruits or seafood.
Study methods
- Clinical method: complaints and physical examination.
- Biochemical method: measurement of glucose, bilirubin, cholesterol, triglycerides, and urea in blood serum.
Blood tests were performed before and after the course of therapy using standard methods. Blood glucose was measured before treatment, then every day during the first week and every five days during the remainder of treatment. In addition, when selecting an oral glucose-lowering therapy regimen, patients' daily blood-glucose fluctuations were monitored and postprandial hyperglycaemia was assessed.
Patient characteristics
The main group included 20 patients, 12 women and 8 men, aged 42 to 63 years; mean age was (52{,}2 pm 4) years. The control group consisted of 20 patients matched for age, sex, and diseases. It included 14 women and 6 men aged 40 to 65 years. Mean age was (51{,}4 pm 11) years. Thus, most patients were of working age.
Before treatment and before the diet enriched with “Vegetabs™ with lemon” was prescribed, biochemical indicators in the main group were as follows: glucose (14{,}0 pm 0{,}4) mmol/L, urea (5{,}8 pm 0{,}4) mmol/L, bilirubin (24{,}5 pm 0{,}6) mmol/L. Cholesterol was (7{,}2 pm 0{,}6) mmol/L, and triglycerides were (2{,}4 pm 0{,}1) mmol/L.
In the control group, biochemical indicators were: glucose (14{,}2 pm 0{,}5) mmol/L, urea (5{,}6 pm 0{,}7) mmol/L, bilirubin (23{,}9 pm 0{,}6) mmol/L. Cholesterol was (7{,}3 pm 0{,}4) mmol/L, and triglycerides were (2{,}52 pm 0{,}12) mmol/L.
Patients in both the main and control groups received standard therapy, including oral glucose-lowering medicines, diet “Table No. 8,” antihypertensive medicines, lipoic-acid medicines, and succinic-acid-based medicines.
Assessment of tolerability of the dietary product
Patients assessed tolerability as: A—good; B—satisfactory; C—poor.
The physician assessed the presence or absence of adverse effects and recorded the data in each patient's individual chart.
Statistical analysis
The study results were analysed using Student's t-test. Differences between groups were considered statistically significant at (mathrm{p} < 0{,}05).
Study results
Blood glucose decreased in all patients in both the main and control groups. Five days after treatment began with adequate doses of oral glucose-lowering medicines, fasting glucose in the main group—patients receiving a diet enriched with dietary fibre—was borderline on day 5 at 6.8 mmol/L. Fasting glycaemia in this group normalised by day 7 and reached the recommended level of 5.9 mmol/L. Thus, the dietary-fibre-enriched diet showed a slight advantage in normalising fasting blood glucose, although the difference was not statistically significant. A different pattern was observed for postprandial glycaemia.
Postprandial glycaemia in the group receiving dietary fibre as part of “Vegetabs™ with lemon” was 7.0 mmol/L after only 10 days, which represents a low risk of vascular complications. In the control group, postprandial glycaemia was 8.7 mmol/L by day 10, a borderline value associated with macrovascular risk. The control group reached an acceptable postprandial glycaemia level only by day 15 (7.6 mmol/L), and it was unstable. In some patients, post-meal glycaemia fluctuations reached 9 mmol/L.
Regarding changes in blood cholesterol, in the group receiving dietary fibre in “Vegetabs™ with lemon,” cholesterol had decreased by 20% to 5.75 mmol/L by the end of the hospital stay. In the group receiving a regular diet, it decreased by 12% to 6.64 mmol/L. Thus, patients receiving dietary fibre as part of their diet were considered at risk only of macroangiopathy, whereas patients on the regular diet were considered at risk of both macroangiopathy and microangiopathy. Triglyceride levels changed more slowly: by the end of the hospital stay, they had decreased to 1.9 and 2.2 mmol/L, respectively, indicating a relatively high risk only of macroangiopathy in the main group and of microangiopathy in the control group. This lipid-metabolism disorder requires further monitoring and treatment; therefore, on discharge, patients were advised to include at least 5 grams of dietary fibre per day in their diet.
Along with the positive effect on carbohydrate and lipid metabolism, patients receiving “Vegetabs™ with lemon” showed normalisation of gastrointestinal function—normal bowel movements, reduced constipation, and less dyspepsia. Blood bilirubin levels normalised by discharge in both groups, and the dynamics of bilirubin levels in type 2 diabetes after dietary fibre was added to the diet require further study. No negative side effects, such as gastrointestinal irritation or allergic reactions to the product, were identified. Patients noted the product's pleasant taste and convenience in the form of chewable tablets.
Conclusion
Adding dietary fibre “VegetabsTM with lemon” to the diet of people with diabetes contributed to faster normalisation of carbohydrate metabolism indicators and made it possible to significantly reduce postprandial glycaemia. Adding “VegetabsTM with lemon” dietary fibre also led to a greater reduction in cholesterol and triglyceride levels in cases of moderate lipid-metabolism disorders. Enriching the diet of patients with type 2 diabetes with “VegetabsTM with lemon” dietary fibre normalised bowel function.
Thus, the dietary-fibre-based product “VegetabsTM with lemon” may be recommended as a component of comprehensive dietary support for patients with non-insulin-dependent diabetes mellitus, at no less than 5 grams per day.
